IMMUNOTHERAPEUTIC FORMULATIONS TO GENERATE AUTOANTIBODIES CAPABLE TO AVOID THE BINDING OF INTERLEUKIN-2 TO ITS RECEPTOR.THEIR USE IN THE TREATMENT OF CANCER
THE PRESENT INVENTION IS RELATED TO PHARMACEUTICAL COMPOSITIONS BASED ON VACCINES AND MONOCLONAL ANTIBODIES THAT NEUTRALIZE THE INTERLEUKIN-2, WHICH ARE USEFUL IN THE TREATMENT OF TUMORS. PARTICULARLY THE PRESENT INVENTION IS RELATED TO THERAPEUTIC FORMULATIONS ABLE TO INCREASE THE IMMUNOGENICITY OF...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English |
Published |
31.05.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!